News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety Alerts Gabapentin and Pregabalin Potential for Misuse Public Health England and NHS England have published advice for prescribers on the risk of misuse of gabapentin and pregabalin. For more information, click here.   Hot Topics Drugs […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety alerts Naloxone – Patient Safety Alert NHS England has produced a Patient Safety Alert warning of the risk of distress and death from inappropriate doses of naloxone in patients on long-term opioid treatment (NHS/PSA/W/2014/016R). The alert […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates Nitrofurantoin contra-indications updated The guidance for using nitrofurantoin in renal impairment has changed. Nitrofurantoin is now contra-indicated in patients with an estimated glomerular filtration rate (eGFR) of <45mL/min/1.73m2. However, a short course (3–7 days) may be […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety alerts Dexamethasone 4mg/mL injection changes Dexamethasone injection 4mg/mL (Organon) has been acquired by Aspen pharmaceuticals. They have reformulated the product and it now contains 3.8mg/mL dexamethasone, available as a 1mL vial, which requires storage in a […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics Electronic prescribing for controlled drugs – DH consultation The UK Department of Health (DH) has published a consultation document on proposals for electronically prescribing Schedules 2 and 3 CDs in both the NHS and privately. […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics Ketamine rescheduling consultation Ketamine was classified as a Class B drug, under the Misuse of Drugs Act, on 10 June 2014 in the UK (see our news item 6 June 2014). The promised consultation document, […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates Class 2 Medicines Recall: Midazolam buccal liquid 10mg/mL (unauthorized) The UK MHRA has issued a class 2 medicines recall (action within 48h) for specific batches of Midazolam buccal liquid 10mg/mL, 5mL (unauthorized product manufactured under […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates Reminder of risk of life-threatening harm from accidental exposure to fentanyl patches The MHRA have sent out a reminder of the potential risk of life-threatening harm from accidental exposure to transdermal fentanyl patches. Cases of […]

Read More…

News and updates from www.palliativedrugs.com

9th June 2014 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics NICE Evidence Update: Opioids in palliative care The UK National Institute for Health and Care Excellence has produced a summary of the selected new evidence relevant to the use of opioids in […]

Read More…

News and updates from www.palliativedrugs.com

2nd May 2014 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates EMA restricts domperidone dose and duration of use The European Medicines Agency (EMA) has recommended changes to the indications, dose and duration of use of domperidone in adults and children following a […]

Read More…